HighVista Strategies »

Savara shares owned by HighVista Strategies

Quarter-by-quarter ownership of Savara (SVRA) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Savara

Tip: Access up to 7 years of quarterly data

All positions including Savara held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Savara by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 251k 5.46

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Spyre Therapeutics Com New (SYRE)
Vaxcyte (PCVX)
Revolution Medicines (RVMD)
Terns Pharmaceuticals (TERN)
Structure Therapeutics Sponsored Ads (GPCR)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Tyra Biosciences (TYRA)
Amylyx Pharmaceuticals (AMLX)
Amazon (AMZN)

View all positions for HighVista Strategies

Top funds holding Savara

NEA Management Company
Bain Capital Life Sciences Investors
VR Adviser
Deerfield Management Company
TCG Crossover Management
BlackRock
Vanguard Group
Frazier Life Sciences Management
Polar Capital Holdings
Vanguard Capital Management
Nantahala Capital Management
State Street Corporation
Rtw Investments
Marshall Wace
Woodline Partners

View all funds holding Savara